Contineum Therapeutics, Inc. (CTNM)
NASDAQ: CTNM · Real-Time Price · USD
15.78
0.00 (0.00%)
At close: Feb 26, 2026, 4:00 PM EST
15.78
0.00 (0.00%)
After-hours: Feb 26, 2026, 4:00 PM EST
Contineum Therapeutics Market Cap
Contineum Therapeutics has a market cap or net worth of $569.86 million as of February 26, 2026. Its market cap has increased by 167.96% in one year.
Market Cap
569.86M
Enterprise Value
391.12M
1-Year Change
167.96%
Ranking
Category
Stock Price
$15.78
Market Cap Chart
Since the IPO on April 5, 2024, Contineum Therapeutics's market cap has increased from $402.09M to $569.86M, an increase of 41.72%. That is a compound annual growth rate of 20.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 25, 2026 | 576.43M | 38.06% |
| Dec 31, 2025 | 417.53M | 10.56% |
| Dec 31, 2024 | 377.64M | -6.08% |
| Apr 5, 2024 | 402.09M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| LB Pharmaceuticals | 626.15M |
| MeiraGTx Holdings | 619.78M |
| Design Therapeutics | 603.82M |
| Alto Neuroscience | 600.20M |
| Ocugen | 583.64M |
| Neumora Therapeutics | 582.89M |
| Altimmune | 572.31M |
| Fulcrum Therapeutics | 566.03M |